Genetic prophecy : beyond the double helix / Zsolt Harsanyi, Richard Hutton.

  • Harsanyi, Zsolt, 1944-
Date:
[1981], ©1981
Catalogue details

Licence: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)

Credit: Genetic prophecy : beyond the double helix / Zsolt Harsanyi, Richard Hutton. Source: Wellcome Collection.

    338/360 (page 322)
    INDEX HLA antigens as (Cont.) for infectious diseases and vac¬ cination reactions, table 65-66 for intelligence, 227-230 for kidney cancer, table 66, 97 for leukemia, 62, 100, 101, 146 for lung cancer, 81-86, 110, 139 for lupus erythematosus, table 64, 140 for malaria and malaria resis¬ tance, 150-153 MAO, 134, 209-210 for mental disorders, table 66, 213, 214-215 for multiple sclerosis, table 66, 213, 215 NAT, 109 for neurological diseases, table 66 for obesity, 125-127 pepsinogen 1, 16, 131-132 for pernicious anemia, table 65, 133 phaeomelanin, 95-96 for PKU, 175, 228-229 proteins as, 21, 215-216, 218-219 for pulmonary diseases, table 66 for renal diseases, table 67 research and future, 29-30 for resistance to certain dis¬ eases, 61, 62, 75, 146, 150-153 for respiratory diseases, 110-112, 113 for rheumatic diseases, table 67, 146 sex chromosomes as, 72, 100, 227-228, 237-240 sickle-cell trait, 114-116, 151-152,153, 218 for skin cancer, 95-96, 146 for skin disorders, table 64-65 sodium potassium ATPase, 125-127 for stomach cancer, 132 taste gene for PTC, 134-135 testing problems, 84-85, 215, 240 for thyroid abnormalities, table 65,134-135 tyramine transaminase, 134 for ulcers, 16, 130-132, 146 for various cancers, table 66, 77, 83, 89, 90-91, 100, 132, 146, 263 for various drug sensitivities, 15, 139-141 for various food sensitivities, 134 Z genes, 111-112, 113 Genetic mutation. See Mutation Genetic Research Group, Insti¬ tute of Society, Ethics and the Life Sciences, 255-256 Genetic screening, 5, 17, 27, 215, 247-273 abuses of, 249-251, 253-255, 257, 262, 271-272 confidentiality, 256-257, 258 danger of stigmatization and stereotyping, 238, 244-245, 252, 258-262, 264, 269 guidelines and safeguards for, 255-257 for HLA type, 76-77, 78 industrial programs, 115-116, 117-118, 121 limited accuracy, 258 mass screening programs, 248-253, 256-257, 258, 265 [ 3^^ ]